Clinical trial NCT05648383 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-02-28 → 2025-12-20 3. primary completion date: 2025-02-28 → 2025-12-20 4. enrollment: 992 → 1215 participants 5. enrollment type: ESTIMATED → ACTUAL 6. primary purpose: TREATMENT → PREVENTION
Clinical trial NCT05673057 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-12-01 → 2027-05-01 3. primary completion date: 2027-12-01 → 2026-05-29
Clinical trial NCT06397989 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-11-01 → 2026-07-01 3. primary completion date: 2026-11-01 → 2026-07-01 4. enrollment: 6700 → 5800 participants
Clinical trial NCT06529146: completion date: 2026-06-01 → 2026-08-01.
Clinical trial NCT06744205 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-16 → 2026-05-22 3. primary completion date: 2026-04-16 → 2026-05-22
Clinical trial NCT07522073: collaborators added: Qiagen Manchester Ltd.
Clinical trial NCT07192211 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-09-01 → 2026-04-28
Clinical trial NCT07221669: start date: 2026-01-30 → 2026-04-28.
Clinical trial NCT07490301 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-04-30
Clinical trial NCT07631286: start date: 2026-05-30 → 2026-06-01.